Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.
about
Research progress of cardioprotective agents for prevention of anthracycline cardiotoxicity.Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.Mitochondrionopathy phenotype in doxorubicin-treated Wistar rats depends on treatment protocol and is cardiac-specificManagement of chemotherapy induced cardiomyopathy.Cardio-oncology: a new medical issue.Chemotherapy-induced cardiotoxicity.Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function.A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases.Use of the ACE inhibitor zofenopril in the treatment of ischemic heart disease.Hepatocyte growth factor regulates angiotensin converting enzyme expressionPoly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failureUse of angiotensin-converting enzyme inhibitors in the prophylaxis of anthracycline or trastuzumab-related cardiac dysfunction: preclinical and clinical considerations.Cardiac safety of systemic therapy in breast cancer patients with high risk of atherosclerosis complications.Cardiac complications of chemotherapy: role of prevention.Cardioprotective Effect of Grape Seed Extract on Chronic Doxorubicin-Induced Cardiac Toxicity in Wistar Rats.Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy.Chronic cardiotoxicity of anticancer anthracyclines in the rat: role of secondary metabolites and reduced toxicity by a novel anthracycline with impaired metabolite formation and reactivity.Effect of green tea extract on Doxorubicin induced cardiovascular abnormalities: antioxidant action.Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril.Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy.Prevention of acute adriamycin cardiotoxicity by dantrolene in rats.Cardiovascular and survival effects of sympatho-inhibitors in adriamycin-induced cardiomyopathy in rats.Astragalus Improved Cardiac Function of Adriamycin-Injured Rat Hearts by Upregulation of SERCA2a Expression.Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT1 R upregulation are required for doxorubicin-induced cardiotoxicity.Cardioprotective effects of fullerenol C(60)(Oh)(24) on a single dose doxorubicin-induced cardiotoxicity in rats with malignant neoplasm.Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.Protecting the heart in cancer therapy
P2860
Q26742059-2A920BD9-DB1B-41F5-9E7D-8305ACA38DA2Q27027354-1C5A6748-CF5A-4271-B53C-E87A05799F49Q27301261-AD159B4D-9C7D-44AE-BBD8-F46D96CDB74EQ30461441-1D124428-B1CF-4B7A-847F-B2476C5002C7Q30471284-A6FFB2F3-D2F8-4D5B-950A-22C6EF8116F4Q34258080-0C8508A1-B9A4-469F-8544-17EC7CAD0E60Q35214168-BCA85C9B-3E78-4562-8B24-A8C8843A1912Q35871881-40C53403-5FEC-4D59-9E60-F5E8B9A971B5Q36642656-AFD60045-119C-4652-ABE5-FDFD887B4E0AQ36740263-D0AF6FB6-3031-4D16-8B02-DBEE1C016A19Q37373704-10AFFB37-665E-460C-A43A-C67B34908FD2Q38503419-253FDA0C-F377-4127-9D0F-7B9BFCAAB23BQ38804715-A66D6367-877F-47C0-9824-FB2856082B92Q39194543-C25F9D5E-3343-4422-9700-C64589D50D24Q39264529-8FB36C59-B458-4D70-AB11-260AF8B656F0Q39898360-ECF421E5-8F3F-426E-9D87-FCE53150835FQ41767370-581314FD-BD95-44D4-9F44-7595BE826D72Q42828271-DFDC305B-999A-47A7-82CE-9ECCB668F636Q42935846-036A7039-2424-4D2F-989B-84F9AA789DD0Q43199588-F00DA8B0-3A6A-4E65-B967-DE75430A2B1BQ44955455-B4AE26FE-BD89-4FFD-8DFC-966CBBB206BBQ45153283-D1D3A50F-83DF-4C82-9959-4C3C7E866CEAQ45928062-18A0B256-BC50-42E4-ADE9-26DAA245C4D7Q46403967-8B6F1E06-C6CD-4684-A1E3-AD7A458A61CAQ46805568-723C5633-C984-4047-A39A-18C33FB324E7Q49315568-CF3BE007-4CDE-4FFA-957F-997834F67FEDQ57821006-6C42F050-1242-436C-A4B8-36E0B5E05912
P2860
Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cardioprotective effects of zo ...... ced cardiotoxicity in the rat.
@ast
Cardioprotective effects of zo ...... ced cardiotoxicity in the rat.
@en
type
label
Cardioprotective effects of zo ...... ced cardiotoxicity in the rat.
@ast
Cardioprotective effects of zo ...... ced cardiotoxicity in the rat.
@en
prefLabel
Cardioprotective effects of zo ...... ced cardiotoxicity in the rat.
@ast
Cardioprotective effects of zo ...... ced cardiotoxicity in the rat.
@en
P2093
P1476
Cardioprotective effects of zo ...... uced cardiotoxicity in the rat
@en
P2093
P356
10.1016/S0014-2999(01)00782-8
P407
P577
2001-02-01T00:00:00Z